India, May 6 -- Pfizer Inc. (PFE) announced that Andrew Baum will be the new Chief Strategy and Innovation Officer, Executive Vice President, effective June 3.
Baum will succeed Aamir Malik, who recently got promoted as the company's Chief U.S. Commercial Officer, Executive Vice President.
"Dr. Baum has a rare profile that combines deep clinical and scientific knowledge with strong financial expertise in fields such as equity research, hedge funds, investment banking and shareholder value creation strategies. As a former experienced analyst who followed Pfizer for over a decade, he will bring fresh strategic insights into the company's business and portfolio," said Dr. Albert Bourla, Chairman and Chief Executive Officer, Pfizer.
Baum's e...